Summary
Bin Chen is a tenured associate professor, entrepreneur, and co-founder who translates large-scale AI and multi-omic data into therapeutic discovery, currently leading the Center for AI-Enabled Drug Discovery at Michigan State and a transcriptomics-driven startup, Bronto Therapeutics. With a PhD in Informatics and a decade of cross-sector experience spanning Stanford, UCSF, big pharma and startups, he builds machine-learning methods for integrative bioinformatics, EHR mining, and drug repurposing. His lab’s work has been published in Cell and Nature-family journals and supported by over $7M in NIH, industry, and foundation funding, reflecting both methodological rigor and translational impact. A standing member of the NIH BDMA study section, he also mentors the next generation of PIs and runs a global data-science nonprofit serving 6,000 members, underscoring his commitment to community building beyond academia. An often-overlooked thread in his career is deep cheminformatics and semantic-web work from early industry collaborations, which continues to inform his integrative, network-based approach to drug discovery.
9 years of coding experience
12 years of employment as a software developer
Ignite; The Startup Garage, Ignite; The Startup Garage at Stanford University Graduate School of Business
Doctor of Philosophy (Ph.D.) Informatics (Track: Cheminformatics Minor: Bioinformatics), Doctor of Philosophy (Ph.D.) Informatics (Track: Cheminformatics Minor: Bioinformatics) at Indiana University Bloomington
B.S chemical engineering, B.S chemical engineering at Chongqing University